ABVC BioPharma Inc.

0.70
0.01 (1.43%)
At close: Mar 03, 2025, 3:53 PM
0.67
-4.35%
After-hours: Mar 03, 2025, 04:00 PM EST

ABVC BioPharma Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02
Net Income -10.52M -16.31M -12.04M -10.59M -3.93M -4.1M -6.67M -4.51M -32.28K -70 -226.35K -1.07M -1.22M -1.9M -5.18M -6.77M -4.65M -25.4K -16.36K 2.54K -25.36K -20K
Depreciation & Amortization 28.53K 23.8K 11.99K 37.14K 55.09K 43.61K 44K n/a n/a n/a 23.86K 33.05K 34.18K 45.25K 45.08K 37.49K 12.76K n/a n/a n/a n/a n/a
Stock-Based Compensation 1.64M 7.04M 5.31M 4.15M 22.31K 28.8K 155.4K 1.3M 30K n/a n/a 196.12K 730.24K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Working Capital 748.4K 1.22M -1.44M -1.01K 666.86K 794.55K 840.43K -280.6K 5.12K n/a 84.04K 335K 131.01K 175.62K 165.09K n/a n/a n/a n/a -7.86K 7.96K -40K
Other Non-Cash Items 3.52M 353.04K -91.05K 2.16M 204.34K 2.55M 4.32M -5.18M -23.04K n/a n/a -217.55K -1.98M 671.92K 3.5M 3.25M 1.96M n/a -1.32K n/a -15.18K 50K
Deferred Income Tax 115.67K 864.8K 824.2K -223.2K -80.69K -366.95K -360.39K n/a n/a n/a n/a n/a 1.22M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital 976.96K 635.57K -1.61M -86.43K 597.67K 892.31K 824.81K -262.23K 5.64K 1.24K 164.72K 142.84K -380.59K 136.66K 77.82K 1.14M -14.74K 49.85K -742 -9.98K 40.9K -40K
Operating Cash Flow -4.24M -7.4M -7.6M -4.56M -3.13M -630.2K -1.68M -3.47M 3.36K 1.17K -37.77K -915.12K -1.59M -1.05M -1.56M -2.34M -2.69M 24.45K -18.43K -7.45K 355.00 -10K
Capital Expenditures -21.2K -119.69K -17.5K n/a n/a n/a n/a n/a n/a n/a n/a -19.55K -41.74K -11.37K -59.44K -215.94K -97.56K n/a n/a n/a n/a n/a
Acquisitions -338.99K -1.6M -680.92K n/a -17.8K n/a -7.8M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a -1.6M -107.55K n/a -17.8K -156.37K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a 3.2M 788.46K 147.8K n/a n/a 128.48K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a -1.6M -788.46K -373.24K 305.00 -156.37K 180.91K n/a n/a n/a n/a n/a 3K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow -360.19K -1.72M -805.97K -225.43K -35.3K -156.37K -7.49M n/a n/a n/a n/a -19.55K -38.74K -11.37K -59.44K -215.94K -97.56K n/a n/a n/a n/a n/a
Debt Repayment 462.62K 350K -177.74K 1.95M 2M 593K 3.58M n/a n/a n/a 25K 221.27K 55.9K 570.42K -297.38K 708K 378.83K n/a n/a -4.54K -12.04K n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 30K
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 2.41M n/a -946.16K n/a 552.96K n/a -2.02M 303.41K n/a n/a n/a 1.26M 1.65M 491K 913.5K n/a n/a n/a n/a -10.95K 10.95K 10K
Financial Cash Flow 3.92M 4.01M 10M 9.57M 3.09M 593K 9.33M 2.65M 995.54K -1.79K 25K 876.27K 1.7M 1.06M 641.12K 2.72M 2.86M n/a n/a -15.49K 103.21K 10K
Net Cash Flow -674.95K -5.17M 1.56M 4.84M -82.34K -37.2K 156.46K -821.29K 998.9K -618 -12.77K -58.4K 68.97K 2.81K -974.28K 166.11K 71.78K 24.45K -18.43K -22.94K 103.56K n/a
Free Cash Flow -4.26M -7.52M -7.62M -4.56M -3.13M -630.2K -1.68M -3.47M 3.36K 1.17K -37.77K -934.67K -1.63M -1.06M -1.62M -2.55M -2.79M 24.45K -18.43K -7.45K 355.00 -10K